Financing led by psychedelic investment fund Negev Capital VANCOUVER, BC — Filament HealthCorp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament”or the “Company”), a clinical-stage natural psychedelic drug development company, is pleased to announce an… Read More
VANCOUVER, BC — Management of mechanically ventilated patients can be complex due to the difficulty in directly assessing the impacts to the heart and lung following clinical interventions. Rostrum Medical,… Read More
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announce… Read More
TRODELVY has now improved survival in both pre-treated HR+/HER2- metastatic breast cancer and in second-line metastatic triple-negative breast cancer. MISSISSAUGA, ON — /CNW/ — Gilead Sciences Canada, Inc. (Gilead Canada) today… Read More
WELL is entering into a strategic alliance with MCI that includes the acquisition of certain clinic assets of MCI that are expected to generate annual revenues of more than $21M… Read More
